Tanya R Thompson, LCSW in Albany, OR - Medicare Social Worker Provider

Tanya R Thompson, LCSW is a medicare enrolled "Social Worker - Clinical" provider in Albany, Oregon. Her current practice location is 445 3rd Ave Sw, Albany, Oregon. You can reach out to her office (for appointments etc.) via phone at (541) 967-3866.

Tanya R Thompson is licensed to practice in Oregon (license number L3150) and she also participates in the medicare program. She does not accept medicare assignments directly but she may accept medicare through third-party (refer to Reassignment section below) and may also prescribe medicare part D drugs. Her NPI Number is 1043306772.

Contact Information

	Tanya R Thompson, LCSW
	445 3rd Ave Sw, Albany, OR 97321-2272
	(541) 967-3866
	(541) 928-3020

Healthcare Provider's Profile

Full Name	Tanya R Thompson
Gender	Female
Speciality	Social Worker - Clinical
Location	445 3rd Ave Sw, Albany, Oregon
Accepts Medicare Assignments	Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs.

NPI Data:

NPI Number: 1043306772
Provider Enumeration Date: 10/04/2006
Last Update Date: 02/27/2019

Medicare PECOS Information:

PECOS PAC ID: 5991963829
Enrollment ID: I20120223000886

Medical Identifiers

Medical identifiers for Tanya R Thompson such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1043306772	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
1041C0700X	Social Worker - Clinical	L3150 (Oregon)	Primary

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Tanya R Thompson allows following entities to bill medicare on her behalf.

Entity Name	County Of Linn
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1760575781 PECOS PAC ID: 7911984638 Enrollment ID: O20040701000264

News Archive

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

AstraZeneca today announced that on March 7, 2012, the Food and Drug Administration denied Citizen Petitions requesting that the FDA withhold finally approving any generic quetiapine product with labeling that omits certain hyperglycemia warning language that the FDA required AstraZeneca to include in the labeling for SEROQUEL (quetiapine fumarate) tablets and SEROQUEL XR (quetiapine fumarate) extended-release tablets.

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Incyte Corporation (Nasdaq: INCY) announced today that it has entered into a clinical trial collaboration agreement with Merck, through a Merck subsidiary, to evaluate the safety and efficacy of Incyte's oral indoleamine dioxygenase-1 (IDO1) inhibitor, INCB24360, and Merck's investigational anti-PD-1 immunotherapy, MK-3475, in a Phase I/II study in previously treated metastatic and recurrent non-small cell lung cancer (NSCLC), and other advanced or metastatic cancers.

Study shows e-cigarette use may increase quit attempts and reduce smoking

As e-cigarettes become more popular, fewer people are taking up smoking traditional cigarettes. But can e-cigarettes, an electronic nicotine delivery system, help people quit smoking altogether? That was the focus of a recent study led by a Hollings Cancer Center researcher.

Children with polyarticular JIA benefit from early and aggressive therapy

Children with juvenile arthritis who are treated early and aggressively have better outcomes, according to research presented this week at the American College of Rheumatology Annual Scientific Meeting in Chicago.

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Tanya R Thompson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Tanya R Thompson, LCSW Po Box 100, Albany, OR 97321-0031 Ph: (541) 967-3866	Tanya R Thompson, LCSW 445 3rd Ave Sw, Albany, OR 97321-2272 Ph: (541) 967-3866

News Archive

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Study shows e-cigarette use may increase quit attempts and reduce smoking

Children with polyarticular JIA benefit from early and aggressive therapy

Social Worker in Albany, OR

John Corbett Caster, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 630 4th Ave Se, Albany, OR 97321 Phone: 541-254-0158
Malia P. Delohery-dart, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866 Fax: 541-672-7146
Mick Fredrickson, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 425 2nd Ave Sw Ste 102, Albany, OR 97321 Phone: 541-286-3209 Fax: 541-704-0040
Rosa E Plascencia, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 734 Elm St Sw, Albany, OR 97321 Phone: 541-812-5111
Janet Spencer, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 400 Hickory St Nw Ste 100, Albany, OR 97321 Phone: 541-812-5880
Meghan West, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2730 Pacific Blvd Se, Albany, OR 97321 Phone: 541-967-3866

Tanya R Thompson, LCSW - Medicare Clinical Social Worker in Albany, OR

Contact Information

Healthcare Provider's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medicare Reassignments

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Study shows e-cigarette use may increase quit attempts and reduce smoking

Children with polyarticular JIA benefit from early and aggressive therapy

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

FDA denies AstraZeneca Citizen Petitions on SEROQUEL labeling

Incyte enters into clinical trial collaboration agreement with Merck to evaluate safety of IDO1 inhibitor

Study shows e-cigarette use may increase quit attempts and reduce smoking

Children with polyarticular JIA benefit from early and aggressive therapy

Social Worker in Albany, OR